A detailed history of Bank Of America Corp transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Bank Of America Corp holds 780 shares of DRTS stock, worth $1,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares
780
Previous 780 -0.0%
Holding current value
$1,770
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.84 - $3.35 $224 - $264
-79 Reduced 9.2%
780 $2,000
Q4 2023

Feb 14, 2024

BUY
$2.75 - $3.89 $217 - $307
79 Added 10.13%
859 $2,000
Q1 2023

May 12, 2023

BUY
$2.78 - $4.83 $2,140 - $3,719
770 Added 7700.0%
780 $2,000
Q1 2022

May 16, 2022

BUY
$8.92 - $15.3 $89 - $153
10 New
10 $0

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $157M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.